Delivery Order SPE2DB22D1103-SPE2DB25FTBS8

Award Date 11/14/24
Potential Completion Date 11/15/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,461.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of METRONIDAZOLE 500 MG TABLET 500S, with an ultimate completion date of November 6, 2024. The award is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
The federal contract award SPE2DX15D3504|SPE2DX24F07N5 is a delivery order for 4,564,886,813 units of the pharmaceutical product METRONIDAZOLE 500 MG TABLET 500S. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has a ceiling value of $1,096.59 and is a firm fixed-price contract with a completion date of June 13, 2024. This...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., to deliver Metronidazole 500 mg tablets to the Defense Logistics Agency (DLA). The Firm Fixed Price Delivery Order, valued at $1,698.92, has an ultimate completion date of December 11, 2023. The contract is not set aside for any specific type of business. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,031.38 firm fixed-price delivery order is for 4,565,217,898 units of the pharmaceutical drug Metronidazole 250 mg tablets. The award has an ultimate completion date of July 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,547.25 delivery order contract is for the supply of Metronidazole 500 mg tablets, a medication used to treat certain bacterial and parasitic infections. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $2,645.42, is for the delivery of 4,564,803,623 tablets of Metronidazole 500 mg, a generic antibiotic medication. This is a Delivery Order contract with a Firm Fixed Price pricing type, with a completion date of June 5, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued at $2,119.70 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Metronidazol 250mg tablets, a generic medication used to treat various bacterial and parasitic infections. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Metronidazole 500 mg tablets. The contract has a ceiling value of $2,332.47 and an ultimate completion date of August 28, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for...
This is a delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,170.30 firm fixed-price contract is for the delivery of 4,565,614,607 tablets of Metronidazole 500 mg. The contract has an ultimate completion date of August 29, 2024 and was awarded on August 28, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is valued at $2,343.50 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025. The current award is for the supply of 4,565,704,537 units of Metronidazole 250 mg Tablets in 250-count bottles. This pharmaceutical product...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTBS8
    Delivery Order

This federal contract award is a delivery order for METRONIDAZOLE 500 MG TABLET 500S, issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp. The contract has a ceiling value of $1,747.17 and is a firm fixed-price contract with an ultimate completion date of November 15, 2024. This contract is not set aside for any specific business category.

The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, across multiple therapeutic domains. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/20/25, 1:54 PM